ZYBT
Zhengye Biotechnology Holding Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CN
$1.41
+5.22%Institutional positioning
13F filings over the trailing two quarters
New 2Increased 4Reduced 8Sold out 1
| Filer | Action | Shares | Filed |
|---|---|---|---|
| XTX Topco Ltd | Increased | 48,865 | Aug 14, 2026 |
| XTX TOPCO LTD | Reduced | 44,146 | May 15, 2026 |
| WINTON GROUP LTD | Reduced | 33,389 | May 12, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Unchanged | 29,068 | Aug 12, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Unchanged | 29,068 | May 15, 2026 |
| StoneX Group Inc. | New Position | 17,661 | Nov 3, 2026 |
| WINTON GROUP Ltd | Reduced | 12,730 | Aug 7, 2026 |
| UBS GROUP AG | Reduced | 8,036 | May 5, 2026 |
| UBS Group AG | Reduced | 7,992 | Aug 13, 2026 |
| TOWER RESEARCH CAPITAL LLC (TRC) | Increased | 4,912 | May 15, 2026 |
| ROYAL BANK OF CANADA | Unchanged | 1,230 | Aug 14, 2026 |
| ROYAL BANK OF CANADA | Increased | 1,230 | May 15, 2026 |
| MORGAN STANLEY | Reduced | 261 | May 15, 2026 |
| MORGAN STANLEY | Reduced | 248 | Aug 13, 2026 |
| JPMORGAN CHASE & CO | New Position | 134 | Aug 12, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings